InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.
Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNet technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
Type | Public | |
Founded | 2005 | |
HQ | Tel Aviv-Yafo, IL | Map |
Website | inspiremd.com |
USD | |
---|---|
Revenue (FY, 2020) | 2.5m |
Gross profit (FY, 2020) | 83.0k |
Gross profit margin (FY, 2020), % | 3.3% |
Net income (FY, 2020) | (10.5m) |
EBIT (FY, 2020) | (10.4m) |
Market capitalization (7-Apr-2021) | 74.8m |
Closing stock price (7-Apr-2021) | 0.6 |
Cash (31-Dec-2020) | 12.6m |
EV | 63.1m |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.0m | 2.0m | 1.1m | 1.4m | 1.5m | 1.6m | 1.5m | 193.0k | 273.0k | 477.0k | 685.0k | 632.0k | 563.0k | 540.0k | 469.0k | 569.0k | 640.0k | 718.0k | 1.0m | 1.0m | 769.0k | 415.0k | 1.4m | 939.0k | 1.0m | 313.0k |
Cost of goods sold | 640.0k | 801.0k | 574.0k | 547.0k | 674.0k | 750.0k | 625.0k | 584.0k | 349.0k | 514.0k | 897.0k | 543.0k | 497.0k | 478.0k | 438.0k | 495.0k | 493.0k | 565.0k | 714.0k | 726.0k | 571.0k | 488.0k | 912.0k | 811.0k | 739.0k | 433.0k |
Gross profit | 400.0k | 1.2m | 564.0k | 803.0k | 840.0k | 802.0k | 857.0k | (391.0k) | (76.0k) | (37.0k) | (212.0k) | 89.0k | 66.0k | 62.0k | 31.0k | 74.0k | 147.0k | 153.0k | 293.0k | 277.0k | 198.0k | (73.0k) | 442.0k | 128.0k | 295.0k | (120.0k) |
Gross profit Margin, % | 38% | 60% | 50% | 59% | 55% | 52% | 58% | (203%) | (28%) | (8%) | (31%) | 14% | 12% | 11% | 7% | 13% | 23% | 21% | 29% | 28% | 26% | (18%) | 33% | 14% | 29% | (38%) |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 8.1m | 7.5m | 3.4m | 5.4m | 2.5m | 11.4m | 13.7m | 9.0m | 5.0m | 13.2m | 9.8m | 6.5m | 2.0m | 885.0k | 10.5m | 8.6m | 6.9m | 4.8m | 4.6m | 6.4m | 11.2m | 5.8m | 4.8m | 7.2m | 3.1m | 13.9m |
Accounts Receivable | 614.0k | 1.8m | 2.0m | 1.3m | 2.1m | 2.1m | 1.5m | 493.0k | 397.0k | 719.0k | 728.0k | 546.0k | 432.0k | 542.0k | 471.0k | 451.0k | 538.0k | 754.0k | 916.0k | 710.0k | 464.0k | 861.0k | 796.0k | 856.0k | 416.0k | |
Prepaid Expenses | 71.0k | 103.0k | 89.0k | 94.0k | 91.0k | 144.0k | 110.0k | 215.0k | 138.0k | 109.0k | 76.0k | 62.0k | 41.0k | 107.0k | 21.0k | 73.0k | 109.0k | 53.0k | 71.0k | 145.0k | 66.0k | 44.0k | 155.0k | 63.0k | 40.0k | |
Inventories | 1.5m | 1.9m | 2.0m | 2.0m | 2.0m | 1.4m | 1.3m | 1.5m | 1.7m | 1.8m | 1.2m | 1.1m | 511.0k | 387.0k | 365.0k | 329.0k | 429.0k | 576.0k | 517.0k | 637.0k | 816.0k | 1.4m | 1.2m | 1.3m | 1.2m | 1.4m |
USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | (14.7m) | (7.1m) | (9.3m) | (25.1m) | (15.6m) | (8.5m) | (8.4m) | (7.2m) | (10.0m) | (10.5m) |
Depreciation and Amortization | 89.0k | 69.0k | 188.0k | 263.0k | 241.0k | 191.0k | 178.0k | 152.0k | 158.0k | 151.0k |
Inventories | (261.0k) | 317.0k | (331.0k) | 1.2m | 253.0k | (33.0k) | (601.0k) | (102.0k) | (179.0k) | |
Accounts Payable | (371.0k) | (291.0k) | 737.0k | (659.0k) | (397.0k) | 106.0k | (290.0k) | 584.0k | (283.0k) | (410.0k) |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (4.1m) | (6.4m) | (3.1m) | (9.4m) | (14.3m) | (3.9m) | (6.0m) | (13.5m) | (20.3m) | (5.2m) | (9.1m) | (12.7m) | (2.6m) | (4.6m) | (6.6m) | (2.6m) | (4.9m) | (6.9m) | (2.4m) | (3.0m) | (5.0m) | (3.2m) | (5.4m) | (7.5m) | (2.0m) | (4.5m) |
Depreciation and Amortization | 38.0k | 52.0k | 34.0k | 95.0k | 146.0k | 50.0k | 56.0k | 122.0k | 181.0k | 75.0k | 135.0k | 195.0k | 48.0k | 95.0k | 143.0k | 42.0k | 84.0k | 127.0k | 41.0k | 79.0k | 115.0k | 35.0k | 73.0k | 114.0k | 51.0k | 88.0k |
Inventories | (51.0k) | (233.0k) | (238.0k) | 201.0k | 250.0k | 79.0k | (89.0k) | 174.0k | 695.0k | 843.0k | 242.0k | 366.0k | 388.0k | 171.0k | 71.0k | (76.0k) | 16.0k | (104.0k) | (283.0k) | (313.0k) | (84.0k) | (149.0k) | 34.0k | (166.0k) | ||
Accounts Payable | (340.0k) | (541.0k) | (481.0k) | 60.0k | (65.0k) | 19.0k | (218.0k) | (94.0k) | (75.0k) | (244.0k) | (418.0k) | (75.0k) | (59.0k) | 686.0k | (103.0k) | (267.0k) | (145.0k) | (216.0k) | 184.0k | 148.0k | 128.0k | (57.0k) | (311.0k) | (242.0k) | (84.0k) | (188.0k) |
USD | Q2, 2011 |
---|---|
Financial Leverage | 1.6 x |
InspireMD has 1.51k Twitter Followers. The number of followers has increased 3.1% month over month and increased 21.3% quarter over quarter
269
Tweets
934
Following
1.5k
Followers
11
Tweets last 30 days
9.5
Avg. likes per Tweet
100%
Tweets with engagement
When was InspireMD founded?
InspireMD was founded in 2005.
Who are InspireMD key executives?
InspireMD's key executives are Marvin Slosman, Paul Stuka and Craig Shore.
How many employees does InspireMD have?
InspireMD has 48 employees.
What is InspireMD revenue?
Latest InspireMD annual revenue is $2.5 m.
What is InspireMD revenue per employee?
Latest InspireMD revenue per employee is $51.8 k.
Who are InspireMD competitors?
Competitors of InspireMD include Elanix Biotechnologies, 19Labs and Biovotion.
Where is InspireMD headquarters?
InspireMD headquarters is located at 4 Menorat HaMa'or St, Tel Aviv-Yafo.
Where are InspireMD offices?
InspireMD has offices in Tel Aviv-Yafo and Winsen (Luhe).
How many offices does InspireMD have?
InspireMD has 2 offices.
Receive alerts for 300+ data fields across thousands of companies